Abstract
The role of the GH receptor polymorphisms as a prognostic factor of vertebral fractures in acromegalic patients resistant to first-generation SSAs and treated with Pegvisomant or Pasireotide Lar
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have